Menu
Back to User profile » Dr Sujuan Yuan
Papers published by Dr Sujuan Yuan:
The Preliminary Study for Postoperative Radiotherapy Survival Associated with RUNX3 and TLR9 Expression in Lung Cancer
Gao C, Qiao T, Yuan S, Zhuang X
Cancer Management and Research 2021, 13:4497-4507
Published Date: 4 June 2021
TLR9 signaling activation at different stages in colorectal cancer and NF-kappaB expression
Gao C, Qiao T, Zhang B, Yuan S, Zhuang X, Luo Y
OncoTargets and Therapy 2018, 11:5963-5971
Published Date: 18 September 2018
Antitumor effects of nadroparin combined with radiotherapy in Lewis lung cancer models
Zhuang X, Qiao T, Yuan S, Zhang Q, Chen W, Luo Y, Xu G
OncoTargets and Therapy 2018, 11:5133-5142
Published Date: 24 August 2018
Efficacy and safety of adding an agent to bevacizumab/taxane regimens for the first-line treatment of Her2-negative patients with locally recurrent or metastatic breast cancer: results from seven randomized controlled trials
Liu XQ, Liu XD, Qiao TK, Chen W, Yuan SJ
OncoTargets and Therapy 2016, 9:3771-3781
Published Date: 30 June 2016
CpG oligodeoxyribonucleotide 7909 enhances radiosensitivity via downregulating Oct-4 expression in radioresistant lung cancer cells
Xing N, Qiao T, Zhuang X, Yuan S, Zhang Q, Xu G
OncoTargets and Therapy 2015, 8:1443-1449
Published Date: 12 June 2015
Dose-effect relationship of CpG oligodeoxyribonucleotide 1826 in murine Lewis lung cancer treated with irradiation
Zhuang XB, Qiao TK, Yuan SJ, Chen W, Zha L, Yan L
OncoTargets and Therapy 2013, 6:549-554
Published Date: 20 May 2013
Impact of CHK2-small interfering RNA on CpG ODN7909-enhanced radiosensitivity in lung cancer A549 cells
Chen W, Liu XQ, Qiao TK, Yuan SJ
OncoTargets and Therapy 2012, 5:425-431
Published Date: 3 December 2012